Trial Profile
Efficacy Of Switching From SSRI to Desvenlafaxine on Cognitive Function In Patients With an Acute Episode of Major Depression
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 17 Apr 2019 Planned End Date changed from 3 Apr 2019 to 3 Jun 2019.
- 17 Apr 2019 Planned primary completion date changed from 3 Apr 2019 to 3 Jun 2019.
- 17 Apr 2019 Status changed from not yet recruiting to recruiting.